545 related articles for article (PubMed ID: 15549428)
1. Pathogenesis of carcinoma of the papilla of Vater.
Fischer HP; Zhou H
J Hepatobiliary Pancreat Surg; 2004; 11(5):301-9. PubMed ID: 15549428
[TBL] [Abstract][Full Text] [Related]
2. [Pathogenesis and histomorphology of ampullary carcinomas and their precursor lesions. Review and individual findings].
Fischer HP; Zhou H
Pathologe; 2003 May; 24(3):196-203. PubMed ID: 12739053
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma of the ampulla of Vater: comparative histologic/immunohistochemical classification and follow-up.
Zhou H; Schaefer N; Wolff M; Fischer HP
Am J Surg Pathol; 2004 Jul; 28(7):875-82. PubMed ID: 15223956
[TBL] [Abstract][Full Text] [Related]
4. Differences in mucus and K-ras mutation in relation to phenotypes of tumors of the papilla of vater.
Matsubayashi H; Watanabe H; Yamaguchi T; Ajioka Y; Nishikura K; Kijima H; Saito T
Cancer; 1999 Aug; 86(4):596-607. PubMed ID: 10440687
[TBL] [Abstract][Full Text] [Related]
5. The clinicopathologic and immunohistochemical characteristics of ampulla of Vater carcinoma: the intestinal type is associated with a better prognosis.
Roh YH; Kim YH; Lee HW; Kim SJ; Roh MS; Jeong JS; Jung GJ
Hepatogastroenterology; 2007 Sep; 54(78):1641-4. PubMed ID: 18019683
[TBL] [Abstract][Full Text] [Related]
6. Does ampullary carcinoma arise from distended glands in the papilla of Vater?
Sonoue H; Suda K; Nobukawa B; Abe H; Arakawa A; Hirai S; Matsumoto T
J Hepatobiliary Pancreat Surg; 2008; 15(2):161-8. PubMed ID: 18392709
[TBL] [Abstract][Full Text] [Related]
7. Neoplastic diseases of the papilla of Vater.
Kimura W; Futakawa N; Zhao B
J Hepatobiliary Pancreat Surg; 2004; 11(4):223-31. PubMed ID: 15368105
[TBL] [Abstract][Full Text] [Related]
8. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes.
Sanada Y; Yoshida K; Konishi K; Oeda M; Ohara M; Tsutani Y
Oncol Rep; 2006 May; 15(5):1157-61. PubMed ID: 16596179
[TBL] [Abstract][Full Text] [Related]
9. Total papillectomy for borderline malignant tumor of papilla of Vater.
Moriya T; Kimura W; Hirai I; Sakurai F; Isobe H; Ozawa K; Fuse A
Hepatogastroenterology; 2004; 51(57):859-61. PubMed ID: 15143934
[TBL] [Abstract][Full Text] [Related]
10. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
[TBL] [Abstract][Full Text] [Related]
11. Cytokeratins 7, 17, and 20 reactivity in pancreatic and ampulla of vater adenocarcinomas. Percentage of positivity and distribution is affected by the cut-point threshold.
Goldstein NS; Bassi D
Am J Clin Pathol; 2001 May; 115(5):695-702. PubMed ID: 11345833
[TBL] [Abstract][Full Text] [Related]
12. Adenoma and tiny carcinoma in adenoma of the papilla of Vater--p53 and PCNA.
Sato T; Konishi K; Kimura H; Maeda K; Yabushita K; Tsuji M; Miwa A
Hepatogastroenterology; 1999; 46(27):1959-62. PubMed ID: 10430377
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma of the ampulla of Vater: morphological and immunophenotypical classification predicts overall survival.
Morini S; Perrone G; Borzomati D; Vincenzi B; Rabitti C; Righi D; Castri F; Manazza AD; Santini D; Tonini G; Coppola R; Onetti Muda A
Pancreas; 2013 Jan; 42(1):60-6. PubMed ID: 22889982
[TBL] [Abstract][Full Text] [Related]
14. [Combined application of immunohistochemical markers to identify pathologic subtypes of ampullary carcinoma and its clinical significance].
Liu FF; Shen DH; Wang HL; Ma YT; Yuan F; Liu J; Chen L; Song QJ; Zhang YY
Zhonghua Bing Li Xue Za Zhi; 2019 Feb; 48(2):92-97. PubMed ID: 30695858
[No Abstract] [Full Text] [Related]
15. Carcinoma of the ampulla of Vater associated with or without adenoma: a clinicopathologic analysis of 198 cases with reference to p53 and Ki-67 immunohistochemical expressions.
Takashima M; Ueki T; Nagai E; Yao T; Yamaguchi K; Tanaka M; Tsuneyoshi M
Mod Pathol; 2000 Dec; 13(12):1300-7. PubMed ID: 11144926
[TBL] [Abstract][Full Text] [Related]
16. Adenomyoma and adenomyomatous hyperplasia of the Vaterian system: clinical, pathological, and new immunohistochemical features of 13 cases.
Handra-Luca A; Terris B; Couvelard A; Bonte H; Flejou JF
Mod Pathol; 2003 Jun; 16(6):530-6. PubMed ID: 12808057
[TBL] [Abstract][Full Text] [Related]
17. A collision tumor composed of cancers of the bile duct and ampulla of Vater--immunohistochemical analysis of a rare entity of double cancer.
Hirono S; Tani M; Terasawa H; Kawai M; Ina S; Uchiyama K; Nakamura Y; Kakudo K; Yamaue H
Hepatogastroenterology; 2008; 55(84):861-4. PubMed ID: 18705284
[TBL] [Abstract][Full Text] [Related]
18. Frequency of colorectal polyps in patients with sporadic adenomas or adenocarcinomas of the papilla of vater--an age-matched, controlled study.
Schneider AR; Seifert H; Trojan J; Stein J; Hoepffner NM
Z Gastroenterol; 2005 Oct; 43(10):1123-7. PubMed ID: 16220451
[TBL] [Abstract][Full Text] [Related]
19. Adenoma and carcinoma of the duodenum and papilla of Vater: a clinicopathologic study.
Seifert E; Schulte F; Stolte M
Am J Gastroenterol; 1992 Jan; 87(1):37-42. PubMed ID: 1728122
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2.
Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM
Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
